POOLBEG PHARMA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.9 GBX | +1.83% |
|
+1.09% | +53.59% |
| 01/05 | Poolbeg Pharma Secures Full Patent in US for Immunomodulator II | MT |
| 01/05 | Poolbeg Pharma celebrates full patent approval for Immunomodulator II | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| POOLBEG PHARMA PLC | Bio Therapeutic Drugs | +1.83% | +1.09% | +53.59% | +57.95% | - | 8.81Cr |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- POLB Stock
- Charts Poolbeg Pharma PLC
- Comparison Chart
